PhosphoSolutions Revenue and Competitors
Estimated Revenue & Valuation
- PhosphoSolutions's estimated annual revenue is currently $1.6M per year.
- PhosphoSolutions's estimated revenue per employee is $221,429
Employee Data
- PhosphoSolutions has 7 Employees.
- PhosphoSolutions grew their employee count by -12% last year.
PhosphoSolutions's People
Name | Title | Email/Phone |
---|---|---|
1 | Antibody Development Director | Reveal Email/Phone |
2 | Director Scientific Marketing | Reveal Email/Phone |
3 | Antibody Development Director | Reveal Email/Phone |
4 | President | Reveal Email/Phone |
5 | Customer Support / Research Associate | Reveal Email/Phone |
PhosphoSolutions Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 29 | 480% | N/A | N/A |
#2 | $1.7M | 11 | 22% | N/A | N/A |
#3 | $2.8M | 18 | 13% | N/A | N/A |
#4 | $70.2M | 360 | -3% | N/A | N/A |
#5 | $1.6M | 11 | 38% | N/A | N/A |
#6 | $3.7M | 21 | 5% | N/A | N/A |
#7 | $2.9M | 29 | -9% | N/A | N/A |
#8 | $3.1M | 28 | 75% | N/A | N/A |
#9 | N/A | 9 | -10% | N/A | N/A |
#10 | $2.5M | 16 | -20% | N/A | N/A |
What Is PhosphoSolutions?
PhosphoSolutions is focused on making Antibodies that Work - right off the shelf. Specializing in neuroscience and protein phosphorylation, our antibodies cover a wide range of research areas that include Alzheimer's, Parkinson's, cancer, epilepsy, learning and memory, anxiety, drug abuse, and schizophrenia. In addition, we provide several antibodies directed towards GABA, dopamine and glutamate pathways. Visit our website today and discover Antibodies that Work!
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.6M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.5M | 7 | -12% | N/A |
#2 | $0.9M | 7 | -22% | N/A |
#3 | $0.9M | 7 | -30% | N/A |
#4 | $1M | 7 | -36% | N/A |
#5 | N/A | 7 | 0% | N/A |